Profound Medical Corp.
PROF
$4.78
$0.061.27%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.06M | 179.00K | 773.00K | 428.00K | 0.00 |
| Total Other Revenue | 2.65M | 2.65M | 1.46M | 1.48M | 2.01M |
| Total Revenue | 3.71M | 2.83M | 2.23M | 1.91M | 2.01M |
| Cost of Revenue | 1.18M | 1.03M | 795.00K | 641.00K | 1.02M |
| Gross Profit | 2.52M | 1.81M | 1.44M | 1.27M | 989.00K |
| SG&A Expenses | 6.60M | 6.64M | 5.08M | 4.82M | 5.79M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.46M | 11.82M | 10.07M | 9.39M | 10.83M |
| Operating Income | -8.76M | -8.99M | -7.83M | -7.48M | -8.82M |
| Income Before Tax | -5.57M | -9.19M | -6.90M | -6.16M | -8.89M |
| Income Tax Expenses | -238.00K | 177.00K | 20.00K | 39.00K | -229.00K |
| Earnings from Continuing Operations | -5.33M | -9.36M | -6.92M | -6.20M | -8.66M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.33M | -9.36M | -6.92M | -6.20M | -8.66M |
| EBIT | -8.76M | -8.99M | -7.83M | -7.48M | -8.82M |
| EBITDA | -8.39M | -8.82M | -7.64M | -7.28M | -8.57M |
| EPS Basic | -0.21 | -0.38 | -0.28 | -0.26 | -0.41 |
| Normalized Basic EPS | -0.14 | -0.23 | -0.18 | -0.16 | -0.26 |
| EPS Diluted | -0.21 | -0.38 | -0.28 | -0.26 | -0.41 |
| Normalized Diluted EPS | -0.14 | -0.23 | -0.18 | -0.16 | -0.26 |
| Average Basic Shares Outstanding | 25.77M | 24.54M | 24.44M | 24.30M | 21.37M |
| Average Diluted Shares Outstanding | 25.77M | 24.54M | 24.44M | 24.30M | 21.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |